Literature DB >> 7473650

Neuropsychological characteristics of Huntington's disease carriers: a double blind study.

N K Rosenberg1, S A Sørensen, A L Christensen.   

Abstract

A cohort of 33 people at risk for Huntington's disease (HD), applying for genetic testing, were tested with a battery of neuropsychological tests covering attentional, visuospatial, learning, memory, and planning functions. A psychiatric rating scale, SCL-90R, was also applied, mainly as a control, since cognitive dysfunction could be ascribed to functional disorders as well as neurodegenerative processes. Self-rating did not indicate any psychiatric symptoms in carriers or non-carriers. However, significantly inferior cognitive functioning in the gene carriers was disclosed by the neuropsychological tests. Primarily, attentional, learning, and planning functions were affected. It is concluded that premorbid cognitive decline occurs in HD.

Entities:  

Mesh:

Year:  1995        PMID: 7473650      PMCID: PMC1051633          DOI: 10.1136/jmg.32.8.600

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  Procedural learning and neostriatal dysfunction in man.

Authors:  J A Saint-Cyr; A E Taylor; A E Lang
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

2.  Presymptomatic neuropsychological impairment in Huntington's disease.

Authors:  G W Jason; E M Pajurkova; O Suchowersky; J Hewitt; C Hilbert; J Reed; M R Hayden
Journal:  Arch Neurol       Date:  1988-07

3.  SCL-90: an outpatient psychiatric rating scale--preliminary report.

Authors:  L R Derogatis; R S Lipman; L Covi
Journal:  Psychopharmacol Bull       Date:  1973-01

4.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

5.  A clinico-genetic study of psychiatric disorder in Huntington's chorea.

Authors:  D C Watt; A Seller
Journal:  Psychol Med       Date:  1993       Impact factor: 7.723

6.  Neuropsychological testing of Huntington's patients. Clues to progression.

Authors:  H G Taylor; P Hansotia
Journal:  J Nerv Ment Dis       Date:  1983-08       Impact factor: 2.254

7.  The association of affective disorder with Huntington's disease in a case series and in families.

Authors:  S Folstein; M H Abbott; G A Chase; B A Jensen; M F Folstein
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

8.  Memory impairment associated with progression of Huntington's disease.

Authors:  S J Huber; G W Paulson
Journal:  Cortex       Date:  1987-06       Impact factor: 4.027

9.  Patterns of intellectual deficit in Huntington's disease.

Authors:  R C Josiassen; L Curry; R A Roemer; C DeBease; E L Mancall
Journal:  J Clin Neuropsychol       Date:  1982-07

10.  Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.

Authors:  J C Mazziotta; M E Phelps; J J Pahl; S C Huang; L R Baxter; W H Riege; J M Hoffman; D E Kuhl; A B Lanto; J A Wapenski
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

View more
  12 in total

1.  Intelligence indices in people with a high/low risk for developing Huntington's disease.

Authors:  G M de Boo; A Tibben; J B Lanser; A Jennekens-Schinkel; J Hermans; M Vegter-van der Vlis; R A Roos
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  Verbal episodic memory declines prior to diagnosis in Huntington's disease.

Authors:  Andrea C Solomon; Julie C Stout; Shannon A Johnson; Douglas R Langbehn; Elizabeth H Aylward; Jason Brandt; Christopher A Ross; Leigh Beglinger; Michael R Hayden; Karl Kieburtz; Elise Kayson; Elaine Julian-Baros; Kevin Duff; Mark Guttman; Martha Nance; David Oakes; Ira Shoulson; Elizabeth Penziner; Jane S Paulsen
Journal:  Neuropsychologia       Date:  2007-01-09       Impact factor: 3.139

3.  Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.

Authors:  Jason Rupp; Mario Dzemidzic; Tanya Blekher; Veronique Bragulat; John West; Jacqueline Jackson; Siu Hui; Joanne Wojcieszek; Andrew J Saykin; David Kareken; Tatiana Foroud
Journal:  Neuropsychology       Date:  2011-05       Impact factor: 3.295

4.  Subtle changes among presymptomatic carriers of the Huntington's disease gene.

Authors:  S C Kirkwood; E Siemers; M E Hodes; P M Conneally; J C Christian; T Foroud
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

5.  Parallel explicit and implicit control of reaching.

Authors:  Pietro Mazzoni; Nancy S Wexler
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

6.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

7.  The relationship between cortisol and verbal memory in the early stages of Huntington's disease.

Authors:  Christopher A Shirbin; Phyllis Chua; Andrew Churchyard; Anthony J Hannan; Georgia Lowndes; Julie C Stout
Journal:  J Neurol       Date:  2012-11-20       Impact factor: 4.849

8.  Progression in prediagnostic Huntington disease.

Authors:  Jason Rupp; Tanya Blekher; Jacqueline Jackson; Xabier Beristain; Jeanine Marshall; Siu Hui; Joanne Wojcieszek; Tatiana Foroud
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-01       Impact factor: 10.154

9.  Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion".

Authors:  Jason Brandt; Anjeli B Inscore; Julianna Ward; Barnett Shpritz; Adam Rosenblatt; Russell L Margolis; Christopher A Ross
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

10.  A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease.

Authors:  Mar Puigdellívol; Marta Cherubini; Verónica Brito; Albert Giralt; Núria Suelves; Jesús Ballesteros; Alfonsa Zamora-Moratalla; Eduardo D Martín; Betty A Eipper; Jordi Alberch; Silvia Ginés
Journal:  Hum Mol Genet       Date:  2015-10-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.